Apotex Health Corp. (TSX:APTX)

Market Cap	6.17B
Revenue (ttm)	3.49B +4.2%
Net Income	373.78M
EPS	1.91
Shares Out	228.50M
PE Ratio	87.10
Forward PE	n/a
Dividend	1.05 (3.89%)
Ex-Dividend Date	n/a

Volume	165,250
Open	27.34
Previous Close	27.02
Day's Range	27.05 - 29.24
52-Week Range	24.00 - 29.22
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Apotex Health

Apotex Health Corp. operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India. The company develops, manufactures, and distributes a broad portfolio of prescription and generic pharmaceuticals, oncology biosimilar pharmaceuticals, branded specialty pharmaceuticals, and branded consumer health and wellness products. It operates through three business lines including conventional generic pharmaceuticals; specialty generic pharmaceuticals; and brands & biosimilars. The company has a a strategic partnership ...

• Industry: Pharmaceutical Preparations
• Founded: 1974
• Employees: 6,216
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: APTX

Financial Performance

In fiscal year 2026, Apotex Health's revenue was 3.49 billion, an increase of 4.21% compared to the previous year's 3.35 billion. Earnings were 373.78 million, an increase of 146.39%.